Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > News?

<< Previous

Bullboard Posts

Next >>

Comment by robertshawon Feb 09, 2022 11:59am

493 Views

Post# 34412823

RE:RE:News?

Yajne wrote: Update on Ph2 trial expected "SOON" which will confirm the data needed to apply for break through designation (BTD) for TLD-1433. IMO this will propel sp above $1 initially and possibly significantly higher depending on the full content of the long-awaited NR. JMHO

Nunavuttrader wrote: When do we expect big news? What are the predictions of where this stock could go and in what timeframe?

if we could get the former 7 patients (270 days cancer free) all printed out to be 360 days cancer free( and the former 7 patients which are 180 days cancer free to 270 days cancer free), by the end of this month, we can see $30+ before BTD comes....

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (May 31, 2024)